Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CN |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
|
9.2B CNY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
298.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.8B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
309B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.1B USD |
Loading...
|
Market Distribution
| Min | -2 148% |
| 30th Percentile | 14.3% |
| Median | 23% |
| 70th Percentile | 34.6% |
| Max | 775.2% |
Other Profitability Ratios
Zhejiang Garden Bio-chemical High-tech Co Ltd
Glance View
Zhejiang Garden Bio-chemical High-tech Co Ltd, nestled in the economic heart of China, boasts a robust presence in the global vitamin industry. Established with a keen focus on biosynthesis, the company has carved a niche for itself by specializing in the production of Vitamin D3. As a key player in the vitamin sector, Garden Bio-chemical uses advanced biotechnological methods to convert raw materials such as lanolin, derived from sheep's wool, into highly purified Vitamin D3. This complex process involves carefully monitored steps of extraction and fermentation, ensuring the production of high-quality vitamins that meet stringent international standards. The company’s financial health is intricately tied to its ability to meet the rising demand for vitamins across diverse markets, particularly in health-conscious segments. With the growing global emphasis on nutrition and wellness, Garden Bio-chemical capitalizes on this trend by enhancing its production capabilities and expanding its market reach. The company's revenue model relies heavily on large-scale contracts with pharmaceutical companies, dietary supplement manufacturers, and other sectors that require consistent and reliable supplies of Vitamin D3. By maintaining strong relationships with its clients and continuing to innovate in its production processes, Zhejiang Garden Bio-chemical High-tech Co Ltd ensures sustainability and profitability in an increasingly competitive market.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Zhejiang Garden Bio-chemical High-tech Co Ltd is 54.3%, which is below its 3-year median of 57.6%.
Over the last 3 years, Zhejiang Garden Bio-chemical High-tech Co Ltd’s Gross Margin has decreased from 67.7% to 54.3%. During this period, it reached a low of 54.3% on Sep 30, 2025 and a high of 67.7% on Sep 30, 2022.